273 related articles for article (PubMed ID: 37272017)
21. Paraoxonase-2 (PON2) protects oral squamous cell cancer cells against irradiation-induced apoptosis.
Krüger M; Pabst AM; Al-Nawas B; Horke S; Moergel M
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1757-66. PubMed ID: 25708945
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
23. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
Wang K; Jin J; Ma T; Zhai H
Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
[TBL] [Abstract][Full Text] [Related]
24. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
[TBL] [Abstract][Full Text] [Related]
25. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
[TBL] [Abstract][Full Text] [Related]
26. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
[TBL] [Abstract][Full Text] [Related]
27. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
28. Upregulated circ_0002141 facilitates oral squamous cell carcinoma progression via the miR-1231/EGFR axis.
Wangzhou K; Lu Z; Lai Z; Fu W; Liu C; Tan Y; Hao C
Oral Dis; 2023 Apr; 29(3):902-912. PubMed ID: 34739167
[TBL] [Abstract][Full Text] [Related]
29. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
[TBL] [Abstract][Full Text] [Related]
30. Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI.
Wei Z; Lyu B; Hou D; Liu X
J Invest Surg; 2021 Aug; 34(8):834-841. PubMed ID: 31851859
[TBL] [Abstract][Full Text] [Related]
31. TOMM34 promotes cell proliferation, migration, and invasion of OSCC and modulates mitochondrial function.
Huang Y; Chen Z; Chen X; Chen X; Xu M
J Oral Pathol Med; 2023 Jan; 52(1):47-55. PubMed ID: 36367442
[TBL] [Abstract][Full Text] [Related]
32. Growth differentiation factor 15 as a radiation-induced marker in oral carcinoma increasing radiation resistance.
Schiegnitz E; Kämmerer PW; Rode K; Schorn T; Brieger J; Al-Nawas B
J Oral Pathol Med; 2016 Jan; 45(1):63-9. PubMed ID: 25880686
[TBL] [Abstract][Full Text] [Related]
33. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of Gab1 Inhibits Cellular Proliferation, Migration, and Invasion in Human Oral Squamous Carcinoma Cells.
Xu L; Li J; Kuang Z; Kuang Y; Wu H
Oncol Res; 2018 May; 26(4):617-624. PubMed ID: 28893350
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S
Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331
[TBL] [Abstract][Full Text] [Related]
37. TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis.
Wang D; Qi H; Zhang H; Zhou W; Li Y; Li A; Liu Q; Wang Y
Int J Biol Sci; 2020; 16(7):1180-1193. PubMed ID: 32174793
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA LINC01207 promotes cell proliferation and migration but suppresses apoptosis and autophagy in oral squamous cell carcinoma by the microRNA-1301-3p/lactate dehydrogenase isoform A axis.
Lu X; Chen L; Li Y; Huang R; Meng X; Sun F
Bioengineered; 2021 Dec; 12(1):7780-7793. PubMed ID: 34463208
[TBL] [Abstract][Full Text] [Related]
39. Glaucocalyxin A impairs tumor growth via amplification of the ATF4/CHOP/CHAC1 cascade in human oral squamous cell carcinoma.
Wang X; He MJ; Chen XJ; Bai YT; Zhou G
J Ethnopharmacol; 2022 May; 290():115100. PubMed ID: 35151835
[TBL] [Abstract][Full Text] [Related]
40. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
